Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,079.20
(
-0.87%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
110.37
(
2.07%
)
Bitcoin
68,465.89
(
0.93%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 29423

Thursday, 06/01/2006 11:30:41 AM

Thursday, June 01, 2006 11:30:41 AM

Post# of 257269
>The plus for mnta is the fda refused to approve omnitrope as a true generic and I'd think it's MUCH closer to being an actual copy than any of the others trying with lovenox<

Because the Omnitrope application was a 505b2 rather than an ANDA, I don’t think the FDA had the option of declaring that Omnitrope was a full-fledged generic substitute for Genotropin. If the FDA had done that, PFE might have had a good lawsuit.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up